
Loading, please wait...

Loading, please wait...

A study assessed whether OnabotulinumtoxinA (BoNT-A) treatment affects muscle properties in 22 chronic migraine cases. BoNT-A increased pain thresholds in certain muscles. Muscle relaxation did not appear to have anti-migraine effect. Findings suggest that BoNT-A leads to the desensitization of cutaneous & muscle nociceptors in the head & neck regions, whereas muscle relaxation might not be an important part of the anti-migraine effect.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study assessed whether OnabotulinumtoxinA (BoNT-A) treatment affects muscle properties in 22 chronic migraine cases. BoNT-A increased pain thresholds in certain muscles. Muscle relaxation did not appear to have anti-migraine effect. Findings suggest that BoNT-A leads to the desensitization of cutaneous & muscle nociceptors in the head & neck regions, whereas muscle relaxation might not be an important part of the anti-migraine effect.
2 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today